STAT3 and hepatocellular carcinoma: Recently, we showed that ASGR1 as a tumor suppressor could inhibit STAT3 activation by interacting with NLK in HCC cells.25 The current study reported the identification of DBF4 as another important factor to modulate STAT3 activity.